Uncovering the natural history of prostate cancer
Prostate cancer: clinicians and researchers join forces
Clinicians and researchers are joining forces in a virtual studyathon to explore the natural history of prostate cancer in a large dataset of patients from across the globe. Clinicians, epidemiologists and other researchers are invited to take part.
The aim is to:
– study the clinical management of prostate cancer.
– support clinicians and researchers with better data on the possible outcomes of different treatment options.
– explore the potential to generate and validate more accurate prediction algorithms based on data from Europe, the USA and other parts of the globe.
Unfortunately, there is still surprisingly little data at scale on what the ‘natural history’ (progression of the disease in absence of treatment) is and how co-morbidities (other life-threatening medical conditions) influence the life expectancy of patients diagnosed with prostate cancer. It would greatly aid shared-decision making between clinicians and patients to have a better understanding of which patients will pass away as a result of prostate cancer versus other causes, to establish where treatment would be most effective and to avoid unnecessary interventions for patients.
Joint forces to study the clinical management of prostate cancer
To achieve this clinicians and researchers are joining forces in a virtual studyathon to explore the natural history of prostate cancer in a large dataset of patients from across the globe. The aim of the studyathon is to support clinicians and researchers with better data on the possible outcomes of different treatment options and to explore the potential to generate and validate more accurate prediction algorithms based on data from Europe, the USA and other parts of the globe.
New big data approaches pioneered by OHDSI and EHDEN are changing the way in which medical evidence is generated through systematic large-scale data analysis in health data sources globally. In particular, a studyathon is a focused event in which a large-scale study, which traditionally takes many months to complete, is executed and completed in a few days. This approach has recently been successfully applied to studies in rheumatoid arthritis, hypertension and COVID-19 (see links below), and we now aim to do the same for prostate cancer. Movember is supporting this project too with project design ideas drawn from their experiences in multidisciplinary, global collaboration.
Via PIONEER and EHDEN, datasets with healthcare records for more than 1 million patients with prostate cancer are already accessible for the studyathon, but we are seeking additional data sources with longitudinal data, especially those converted to the OMOP Common Data Model to join this effort. Clinicians, epidemiologists and other researchers interested in this question are also invited to take part.
The studyathon itself will be a five day virtual event on 8-12 March 2021, with sessions every day focused on literature review, phenotype definition, analytics and results interpretation, and will follow the OHDSI approach. Please register your interest via this link and join us in this journey!
PIONEER (Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope) is a European project focused on using big data to improve the clinical understanding and inform the diagnosis and treatment of prostate cancer, funded through IMI2 JU, and is listed under grant agreement No. 777492.
EHDEN (European Health Data & Evidence Network) is a European project focused on generating medical insights at scale from real-world clinical data, funded through IMI2 JU, and is listed under grant agreement No. 806968.
OHDSI (Observational Health Data Sciences and Informatics) is a multi-stakeholder, interdisciplinary open science collaborative aiming to bring out the value of health data through large-scale analytics. Earlier studyathons have resulted in publications in amongst others The Lancet Rheumatology, The Lancet Digital Health and Nature Communications.
PIONEER and EHDEN are funded through the IMI2 Joint Undertaking. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Decarbonising the energy sector: ARTTIC is a partnering in newly launched FLEX4H2 project
The FLEX4H2 project aims at moving technological frontiers for low-emission combustion of hydrogen beyond the latest state-of-the-art The "FLEX4H2" project - Flexibility for Hydrogen - officially started on 1 January 2023. The project, led by Ansaldo Energia, is...
Business Developer (m/f/d)
We are looking for specialists in business development with a strong sales talent and an interest in innovation, research and science. This position is for recent graduates or experienced professionals and involves assisting clients from a variety of industries with...
Team Assistance / Executive Assistant / Office Management (f/m/d)
ARTTIC Innovation GmbH, based in Munich, is the German sister company of ARTTIC SAS. Since our foundation in 1987, we have successfully set up and managed more than 400 collaborative research & development projects. These include projects under the EU Research...
Until when can the R&D tax credits be applied for retroactively for 2020?
Until when can the R&D tax credits be applied for retroactively for 2020?As we wrote in September, the retroactive application for the R&D tax credits is one of its unique selling points in German project funding. But even this generous regulation has its limits....
Senior Innovation Consultant (m/f/d)
We offer you the unique opportunity to become part of a dynamic team in the attractive field of innovation and research. We are looking for specialists with a passion for innovation, scientific writing and project management. This position is for experienced...
Junior Innovation Consultant (m/f/d)
We offer you the unique opportunity to become part of a dynamic team in the attractive field of innovation and research. We are looking for Innovation Consultants with a passion for innovation, scientific writing and project management. This position is for recent...
How can the research allowance get better?
How can the research allowance get better?Accompanying comments on the DIHK short survey of September 6, 2022. A recently published survey by the Association of German Chambers of Industry and Commerce (DIHK) provides revealing insights into how companies perceive the...
Is the research allowance a success?
Is the research allowance a success? - ARTTIC Innovation takes stock Understandably, all stakeholders wonder if the research grant is a success. For a comprehensive evaluation, however, all stakeholders must wait until 2025, when the evaluation by the federal...
E-Magazin – Horizon Europe
E-Magazin Horizon EuropeDo you want to boost your innovation strategy by using Horizon Europe funding?Download the Horizon Europe E-magazine and you will find the tools and information to make a success of your project.
Economic stimulus package doubles research allowance to €1 million per year
The federal government's economic stimulus package provides for an increase in the new tax research allowance from 500,000.00 euros to one million euros, as well as doubling the assessment limit for project costs from two million euros to four million euros.The...